Background and objective Patients with chronic pulmonary hypertension (CPH) who demonstrate pulmonary vasodilation following calcium-channel blocker (CCB) administration are defined as 'responders'. In contrast, 'nonresponders' are patients who do not show such pulmonary vasodilation with CCB therapy. The purpose of this investigation was to study the effects of CCB therapy on right heart mechanics in experimental CCB responders versus CCB nonresponders.
Background and objective Patients with chronic pulmonary hypertension (CPH) who demonstrate pulmonary vasodilation following calcium-channel blocker (CCB) administration are defined as 'responders'. In contrast, 'nonresponders' are patients who do not show such pulmonary vasodilation with CCB therapy. The purpose of this investigation was to study the effects of CCB therapy on right heart mechanics in experimental CCB responders versus CCB nonresponders.
Methods In 12 dogs, right atrial (RA) and ventricular pressure and volume (conductance catheters) were simultaneously recorded after 3 months of progressive pulmonary artery banding. Diltiazem was given at 10 mg h S1 with the pulmonary artery constricted (simulated CCB nonresponder). Responders were then created by releasing the pulmonary artery band to unload the ventricle. RA and right ventricular contractility and diastolic stiffness (slope of end-systolic and end-diastolic pressure-volume relations) were calculated and RA reservoir and conduit function were quantified as RA inflow with the tricuspid valve closed compared with open, respectively.
Results With CCB, RA contractility (P < 0.03) and cardiac output (P < 0.004) were compromised in simulated nonresponders whereas RA stroke work was pharmacologically depressed in the setting of an unchanged afterload. After simulating a responder by controlled pulmonary artery band release, the right atrium became less distensible, causing a shift from reservoir to conduit function (P < 0.001) towards physiological baseline conditions and a recovery in the hyperdynamic compensatory response in both chambers (P < 0.007) as evidenced by declined RA and right ventricular contractility with an improved cardiac output as compared with CPH and simulated nonresponders. RA and right ventricular diastolic function in both groups was not affected by CCB.
Conclusion CCB did not affect right ventricular function in simulated nonresponders but significantly impaired RA contractility and cardiac output. In simulated responders, afterload fell substantially, thereby allowing the right atrium and right ventricle to recover from their pathological hyperdynamic contractile response to CPH. This effect outweighed the intrinsic negative effects of CCB therapy on systolic RA function. Current data suggest that the right atrium in CPH is much more sensitive to CCB therapy than the right ventricle and show for the first time why CCB therapy in CPH has been empirically restricted to documented responders. Eur J Anaesthesiol 26:253-259
Introduction
Historically, calcium-channel blockers (CCBs) have been considered the mainstay therapy and the first-line agent for conventional medical management of primary pulmonary hypertension (PPH); however, side effects including haemodynamic deterioration in some patients have discouraged the initial enthusiasm for the use of CCB [1] [2] [3] [4] . Unpredictable clinical results have led to a paradigm shift towards more restricted use of CCB in recent years. Although the risk of acute haemodynamic impairment may be reduced by using inhaled nitric oxide, adenosine, or intravenous (i.v.) epoprostenol, the appropriate patient selection for this therapeutic approach remains controversial [3, 4] .
Patients who could potentially benefit from long-term treatment may be identified by acute vasodilator challenge [5, 6] . In 'responders', a 20% decrease in pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR) occurs following CCB administration. The reported percentage of patients who turn out to be clinical and haemodynamic long-term responders to CCB treatment is 10-15% [7] . Although multiple animal studies have demonstrated the beneficial vasodilatory effect of CCB on the pulmonary vascular bed in various models of pulmonary hypertension [8] [9] [10] , their complex interactions with right atrial (RA) and right ventricular function have yet to be examined. Specifically, concern exists that CCB therapy in patients who do not demonstrate a decrease in PAP and PVR following CCB administration ('nonresponders') may further impair cardiac function; however, the detailed effects of CCB on right heart mechanics in responders compared with nonresponders remain unknown. Although successful treatment with CCB is restricted to a subgroup of patients, it was recently shown still to be an extremely powerful therapeutic option in long-term responders (5- year survival 97 versus 58% in nonresponders, P ¼ 0.0007) [4] . Therefore, the purpose of the current investigation was to determine the balance between afterload reduction, changes in diastolic relaxation and compliance, and contractile inhibition in an experimental canine CPH model of CCB responders and nonresponders.
Methods

Initial surgical preparation
Twelve adult mongrel dogs of either sex (20-25 kg) underwent a median sternotomy, leaving the pericardium intact. A 5-Fr pressure catheter (Access Technologies, Skokie, Illinois, USA) was introduced into the right ventricular free wall through a purse-string suture and secured in place. An inflatable silastic band (16 mm diameter; Access Technologies) was secured around the distal main pulmonary artery. The pulmonary artery band and right ventricular pressure (RVP) catheter were tunnelled through the left and right lateral chest walls, respectively, and connected to small ports that allowed fluid injection and pressure monitoring [11] .
Creation of chronic right ventricular pressure overload
Approximately 1 week after the initial operation, when the animal fully recovered, RVP overload was initiated in a stepwise manner with progressive inflation of the pulmonary artery band. Inflation of the pulmonary artery band was performed weekly, increasing RVP by 10-20 mmHg at each inflation until near systemic pressures were achieved [12] .
Data acquisition after creation of chronic right ventricular pressure overload Animals underwent a second study, an average of 112 AE 54 days after the initial baseline study. Ultrasonic flow probes (10 to 12-mm perivascular probes with a T206 Flowmeter; Transonic Systems, Ithaca, New York, USA) were placed around the superior vena cava (SVC) and inferior vena cava (IVC) approximately 1 cm from the caval-atrial junction to measure RA inflow. A 1-cm minipericardiotomy was performed over the anterior right ventricular free wall, and a 6-Fr combined pressurevolume conductance catheter (Millar SPR-843; Millar Instruments, Houston, Texas, USA) was introduced through a purse-string suture just below the pulmonary valve and positioned towards the right ventricular apex [12] . A second 1-cm incision was made in the pericardium over the RA appendage, and a 5-Fr combined pressurevolume conductance catheter (Millar SPR-766) was positioned along the long axis of the right atrium so that its tip rested at the RA-IVC junction [11] [12] [13] . The RA and right ventricular pressure-volume catheters were connected to two signal conditioner processors (Sigma 5DF; CD Leycom, Zoetermeer, The Netherlands) [14] .
Data acquisition
Baseline data were recorded during steady-state conditions with the pulmonary artery band inflated to simulate conditions as they appear during chronic pulmonary hypertension (CPH). During each data acquisition run, ECG, right atrial pressure (RAP), RVP, aortic pressure, SVC flow, IVC flow, and RA and right ventricular conductance signals were acquired at 200 Hz and processed using custom-designed computer software. After steadystate data were obtained (three to five beats), slow, progressive vena caval occlusion was performed to generate RA and right ventricular pressure-volume loops over a wide physiological range of filling pressures.
After baseline data were collected, i.v. administration of diltiazem 10 mg h À1 (diltiazem hydrochloride, Novaplus; Bedford, Ohio, USA) was initiated. Following a 20-min stabilization period, data were collected with the pulmonary artery band still inflated to simulate a CCB nonresponder. Finally, the pulmonary artery cuff was released in order to unload the right ventricle (thereby simulating a CCB responder), and standardized data collection was repeated. According to the clinical definition of a CCB responder, we released the pulmonary artery band until a decline by 20-30% of mean pulmonary artery and RVP was monitored.
At the conclusion of the experiment, the animals were euthanized using sodium pentothal (1 g i.v.) followed by potassium chloride (80 meq i.v.), and proper positioning of the catheters was confirmed. All animals received humane care in compliance with the 'Principles of Laboratory Animal Care' formulated by the National Society for Medical Research and the 'Guide for the Care and Use of Laboratory Animals' prepared by the National Academy of Sciences and published by the National Institutes of Health. The study was approved by the Washington University School of Medicine Animal Studies Committee and conducted according to Washington University policy. The authors have chosen to keep to the well established chronic canine model for the purpose of this study, as the complex instrumentation necessary to simultaneously assess right ventricular and RA biomechanics at different levels of right ventricular afterload currently precludes the use of a rodent model.
Data analysis
RA elastance (contractility) was calculated using the 'RA end-systolic' pressure-volume relationship (RA-ESPVR, chamber elastance) as previously described in detail [12, 15] . Similarly, static RA stiffness was defined as the slope of the 'right atrial end-diastolic' pressure-volume relationship (RA-EDPVR).
Right ventricular elastance and stiffness
Similar mathematical methods were used to calculate right ventricular elastance and stiffness as the slope of the right ventricular-ESPVR and right ventricular-EDPVR [16, 17] .
Right ventricular-arterial coupling
Effective arterial elastance (right ventricular E a ) of the pulmonary vascular bed estimates right ventricular afterload and is a function of end-systolic RVP and stroke volume (SV): E a ¼ RVP ES /SV [17] . Effective arterial elastance represents a steady-state approximation of maximum pulmonary vascular impedance. The right ventricular-arterial coupling ratio, E a /E ES , was then computed, which reflects the elastance matching status between the right ventricle and the pulmonary arterial load in the pressure-volume framework. For the ventricle, stroke work is maximal when arterial elastance equals ventricular elastance (E a /E ES ¼ 1); however, pump efficiency is maximized when arterial elastance is onehalf the ventricular elastance (E a /E ES ¼ 0.5) [17] .
RA stroke work As previously described for the left atrium [18] , RA A and V pressure-volume loop areas ( Fig. 1 ) were calculated during the three different haemodynamic states in our study (CPH, CCB nonresponder, CCB responder). Net mechanical work by the right atrium was computed by subtracting the V loop area from the A loop area [19] .
Custom-designed software was used to identify the pressure-volume crossover point between the A and V loop area.
RA reservoir and conduit function
Reservoir and conduit functions of the right atrium were calculated by integrating RA inflow (combined SVC and IVC flow) during right ventricular systole (reservoir) and right ventricular diastole (conduit) [12, 13, 20, 21] .
Statistics
All data are reported as means AE SD. Haemodynamic data obtained during steady-state recording are reported as the average of three consecutive beats. Data were recorded with chronic pulmonary artery banding (CPH) and after subsequent administration of diltiazem 10 mg h À1 with the pulmonary artery band still constricted (CCB nonresponder) and released (CCB responder). The data were compared between the three states using repeated-measures analysis of variance (ANOVA).
Using power analysis, the number of animals studied (n ¼ 12) was selected to yield an 80% power of detecting a one standard deviation difference between various physiological states (a ¼ 0.05). All statistical analyses were performed using SigmaStat 2.03 (SPSS, Inc., Chicago, Illinois, USA). To control for data that were not evenly distributed, we performed normality testing for each paired statistical test prior to selecting a parametric versus nonparametric comparison. Figure 2 illustrates typical haemodynamic changes from one animal, and Table 1 summarizes the steady-state haemodynamic data at CPH (chronic pulmonary artery banding), after CCB administration in simulated CCB nonresponders (persistent PAP elevation), and in simulated CCB responders (pulmonary artery band release).
Results
Overall, with CCB, right ventricular elastance (contractility) did not significantly change in CCB nonresponders but decreased in CCB responders from 15.0 AE 11.3 mmHg ml À1 at baseline to 5.7 AE 3.0 mmHg ml À1 (P ¼ 0.007), associated with a reduction in right ventricular V 0 (volume-axis intercept of the slope of the ESPVR) (P ¼ 0.004). There was no change in right ventricular stiffness (P ¼ 0.58) and right ventricular V ED (volume-axis intercept of the slope of the EDPVR) (P ¼ 0.93) in CCB nonresponders ( Table 2) . Although there was a significant decline in right ventricular elastance in CCB responders, there was a simultaneous decline in right ventricular afterload (E a ) (P < 0.001), resulting in no significant change in the ventriculararterial coupling ratio (E a /E ES ) (P ¼ 0.12).
CCB administration caused RA elastance to fall from 1.8 AE 0.9 mmHg ml À1 at baseline to 1.5 AE 0.6 mmHg ml À1 in CCB nonresponders (P ¼ 0.03) and 0.9 AE 0.4 in CCB Calcium-channel blockers in CPH Zierer et al. 255 responders (P < 0.001 versus baseline). There was no significant change in RA V 0 with either intervention (P ¼ 0.85). Similar to the ventricle, there was also no significant change in RA EDPVR with either intervention (P ¼ 0.84 stiffness, P ¼ 0.92 intercept) ( Table 3) .
Net RA mechanical work (A loop area minus V loop area) significantly dropped from CPH (1.8 AE 1.6) to CCB nonresponders (0.8 AE 1.0, P ¼ 0.02) and further declined in simulated CCB responders (0.0 AE 0.9, P < 0.001) (Table 4) .
At CPH, reservoir function accounted for 68 AE 21% of RA inflow (12 AE 4 ml) and conduit function for 32 AE 27% (5 AE 2 ml). With CCB administration, there was no change in reservoir (68 AE 13%, 10 AE 1 ml) versus conduit (32 AE 13%, 4 AE 2 ml) function in CCB nonresponders (P ¼ 0.38); however, in CCB responders, the RA became less distensible, evidenced by a shift from reservoir (53 AE 18%, 7 AE 3 ml) to conduit (47 AE 18%, 7 AE 3 ml) function (P < 0.001).
Discussion
The results of this study demonstrated the complexity of the interplay between the right atrium and right ventricle in a state of chronic pressure overload. With CCB, RA contractility and cardiac output were significantly compromised in simulated nonresponders whereas RA stroke work was pharmacologically depressed in the setting of an unchanged afterload. After simulating a responder by Typical haemodynamic data obtained with calcium-channel blocker (administration in simulated calcium-channel blocker nonresponders and calcium-channel blocker responders after 3 months of progressive pulmonary artery banding). Three steady-state beats of the right ventricle (darker line above) and right atrium (lighter line below) are illustrated for each haemodynamic state. CCB, calcium-channel blocker; CPH, chronic pulmonary hypertension; RA, right atrial; RV, right ventricular. controlled pulmonary artery band release, the RA became less distensible, causing a shift from reservoir to conduit function towards physiological baseline conditions and a recovery in the hyperdynamic compensatory response in both chambers as evidenced by a declined RA and right ventricular contractility with an improved cardiac output as compared with CPH and simulated nonresponders.
Current findings showed for the first time that CCB therapy in simulated nonresponders impaired RA contractility in the setting of persistently elevated right ventricular afterload, thereby affecting right heart throughput in a negative way. Prior to any manipulation, Hoit et al. [18] demonstrated in control dogs that A and V loop pressure-volume areas from the left atrium were similar in size. Consequently, the net left atrial work (A loop area minus V loop area) was not significantly different from zero. In our study of right heart mechanics, in the setting of chronic pressure overload, the RA A loop area was five-fold higher than the V loop area, consistent with increased RA work, potentially due to a physiological hyperdynamic response. With diltiazem administration in simulated nonresponders, RA work decreased (P < 0.001). Intuitively, this appears counterproductive; in the presence of persistent RVP overload, increased RA work would be necessary to maintain right ventricular filling and cardiac output. Thus, pharmacological depression with CCB administration in simulated nonresponders produced an undesirable fall in cardiac output.
Compromised RA contractility and RA stroke work in simulated nonresponders seems particularly disturbing as previous work from our laboratory suggested that RA function plays an increased role in maintaining right ventricular output when the ventricle begins to fail [12, 22, 23] . Interestingly, right ventricular function was not altered by CCB in simulated nonresponders.
It has been well described that CCB reduces the amount of sarcoplasmatic reticular Ca 2þ release, which results in myofilament cross-bridge formation and subsequent myocyte contraction [24] . Therefore, we could have expected CCB to impair right ventricular contractility, as previous studies have demonstrated in isolated myocytes [24, 25] . Other investigators, however, have shown that the right ventricular compensatory response to chronic pressure overload is one of increased contractility at the expense of impaired diastolic function due to myocardial hypertrophy and subsequent remodelling [12, 26, 27] . Although mild myocardial hypertrophy does not appear to affect L-type Ca 2þ channel abundance and function, the development of moderate-to-severe hypertrophy has been associated with diminished Ca 2þ channel density and activity [24] . In rats chronically exposed to hypobaric conditions, Chouabe et al. [28] reported that the development of right ventricular hypertrophy was associated with a 27% reduction in L-type Ca 2þ abundance. In the current study, we did not quantify the degree of right ventricular or RA hypertrophy, and histological evaluation of the right atrium and ventricle was not performed. In a similar preparation, however, Hsieh et al. [29] induced pulmonary hypertension in dogs and found moderate-to-severe myocyte hypertrophy in the right ventricular outflow tract compared with only mild hypertrophy within the atrium.
To simulate CCB responders, the pulmonary artery band was released, which acutely unloaded the right heart. Heart rate fell by 16% compared with baseline, and right ventricular contractility decreased substantially, characterized by a decrease in right ventricular ESPVR and right ventricular dP/dt, consequent to the 37% fall in RVP. These findings are consistent with reversal of the normal hyperdynamic response of the right ventricle to CPH [11] . The substantial fall in afterload enabled the heart to augment cardiac output despite a decline in the RA and right ventricular hyperdynamic contractile response. Thus, both the slower heart rate and the diminished right ventricular and RA contractility can be interpreted as a beneficial recovery which made the RA and right ventricular work more economic than in CCB nonresponders. With diminished right ventricular afterload, the further decline in RA work can also be judged as a beneficial effect.
After pulmonary artery band release in the current study, the right atrium became less distensible, causing a shift Calcium-channel blockers in CPH Zierer et al. 257 from RA reservoir to conduit function. In a previous report from our laboratory, Gaynor and associates [12] identified a substantial rise in reservoir function from 49% to 72% with chronic RVP overload, consistent with the increase in atrial distensibility that previous investigators predicted would have a positive impact on cardiac output [20, 30, 31] . By creating a CCB responder, we eliminated the cause of the RA shift towards augmented distensibility, with reservoir function falling back to its normal physiological range [12] .
It is well accepted that myocardial relaxation is highly dependent upon calcium flux and that relaxation occurs as the sarcoplasmatic reticulum reaccumulates free ionized calcium, causing it to dissociate from troponin C. Interestingly, bichamber stiffness, quantified using the RA and right ventricular EDPVR, did not substantially fall in CCB nonresponders or CCB responders. As described above, the effects of CCB are dependent on L-type Ca 2þ channel density and are, therefore, likely to be diminished in hypertrophic right ventricular myocardium. Downregulation of calcium-handling proteins, including sarcoplasmic reticulum Ca 2þ -ATPase2a (SER-CA2a) and phospholamban (PLB), has been described in the failing heart [32] . These proteins are important regulators of intracellular calcium homeostasis and have been implicated in myocardial dysfunction; reduction in these proteins is associated with increased calcium transient times. Despite only mild morphological changes within the right atrium, these findings may, in part, explain why there were no changes in bichamber EDPVR in the current report; however, further investigations will be necessary to delineate the molecular mechanisms responsible for these findings.
In summary, CCB did not alter right ventricular function in simulated nonresponders but significantly impaired RA function culminating in a decline in cardiac output. In simulated CCB responders, afterload fell dramatically to improve cardiac output despite a reversal of the pathological hyperdynamic RA and right ventricular contractile response to CPH. This mechanism may explain favourable long-term results observed in clinical CCB responders. In the clinical setting, such right ventricular afterload reduction is dependent on pulmonary vasodilation. Thus, the current study also suggests that, once vascular hypertrophy and remodelling of the smooth muscle cells prevent reversal of pulmonary vasoreactivity (CCB nonresponders), patients are subject to haemodynamic impairment mainly as a consequence of compromised RA function.
Potential limitations
Our model of pulmonary artery banding does not perfectly represent a CPH scenario in humans as it is the small vessels that are mainly affected in these patients. Injecting monocrotaline, an alkaloid known to produce progressive pulmonary hypertension in certain species, is a well described alternative technique but is limited by its ability to cause only a modest rise in RVP and was therefore not deemed suitable for the purpose of the current investigation. The same standardized study protocol used for this report has also served for a previous study from our laboratory at Washington University in St. Louis, School of Medicine [12] . Using the same chronic instrumentation, RA and RVP and volume were recorded at baseline and after 3 months of progressive pulmonary artery banding. Right ventricular elastance and stiffness both increased (P < 0.05), suggesting preserved right ventricular systolic function but impaired right ventricular diastolic function (decreased right ventricular compliance). In another previous chronic canine study using similar instrumentation, right ventricular hypertrophy in response to chronic pulmonary artery banding has been demonstrated [29] . Although we did perform echocardiography periodically to monitor the development of right ventricular dilation and CPH, we did not specifically quantify right ventricular hypertrophy and did not store the echo images to allow later reevaluation. We did perform MRI studies on three dogs as a pilot study in which we did see thickened right ventricular wall, but these data remain anecdotal. Although RA conductance volume was not corrected for parallel conductance (resistance to current due to surrounding tissues), the analytical methods employed in this study were not dependent on absolute volume measurements and were consistent with previous studies involving the right atrium [11] . The shorter time period, as compared with the clinical setting of CPH, is another shortcoming of the current chronic canine model; however, the study endpoint was defined as the development of clinical signs of right heart failure, which typically developed after 3 months of progressive pulmonary artery banding.
